Johnson & Johnson has temporarily paused its clinical trials for a potential novel coronavirus vaccine after an “unexplained illness” in a study participant, the company said Monday.
In a statement posted to its website, the company said the person’s illness is being reviewed and evaluated by the independent Data Safety Monitoring Board along with the company’s own physicians.
The company assured that such “serious adverse events” are not uncommon in clinical trials. It’s also not clear if the illness came from the vaccine candidate itself or from a placebo.
“Adverse events — illnesses, accidents, etc. — even those that are serious, are an expected part of any clinical study, especially large studies,” the company’s statement reads.
More to come..
© 2020 Global News, a division of Corus Entertainment Inc.